Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.7579
-0.0031 (-0.41%)
At close: Jul 25, 2025, 4:00 PM
0.7601
+0.0022 (0.29%)
After-hours: Jul 25, 2025, 5:37 PM EDT

Nautilus Biotechnology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Selling, General & Admin
29.633128.925.9521.153.31
Upgrade
Research & Development
49.0850.4847.2537.6729.3512.43
Upgrade
Operating Expenses
78.7181.4876.1563.6250.515.74
Upgrade
Operating Income
-78.71-81.48-76.15-63.62-50.5-15.74
Upgrade
Interest & Investment Income
10.1310.7812.555.820.33-
Upgrade
Other Non Operating Income (Expenses)
-2.89-2.89-2.73-1.010.170.14
Upgrade
EBT Excluding Unusual Items
-71.47-73.58-66.33-58.81-50-15.61
Upgrade
Gain (Loss) on Sale of Investments
2.82.82.660.89-0.18-
Upgrade
Gain (Loss) on Sale of Assets
-----0.14-0.01
Upgrade
Pretax Income
-68.66-70.78-63.68-57.92-50.32-15.62
Upgrade
Net Income
-68.66-70.78-63.68-57.92-50.32-15.62
Upgrade
Net Income to Common
-68.66-70.78-63.68-57.92-50.32-15.62
Upgrade
Shares Outstanding (Basic)
1261251251258429
Upgrade
Shares Outstanding (Diluted)
1261251251258429
Upgrade
Shares Change (YoY)
0.50%0.41%0.27%47.51%190.36%379.48%
Upgrade
EPS (Basic)
-0.55-0.56-0.51-0.46-0.60-0.54
Upgrade
EPS (Diluted)
-0.55-0.56-0.51-0.46-0.60-0.54
Upgrade
Free Cash Flow
-59.27-62.03-54.15-48.13-41.51-14.92
Upgrade
Free Cash Flow Per Share
-0.47-0.49-0.43-0.39-0.49-0.51
Upgrade
EBITDA
-76.79-79.5-74.3-62.4-49.48-15.03
Upgrade
D&A For EBITDA
1.921.981.851.221.020.71
Upgrade
EBIT
-78.71-81.48-76.15-63.62-50.5-15.74
Upgrade
Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q